Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,433 | -83,724 | -5,339 | -9,926 | -19,322 |
| Depreciation Amortization | -4,920 | -2,218 | 111 | 114 | 91 |
| Accounts payable and accrued liabilities | -5,320 | 9,484 | 28 | -783 | -411 |
| Other Working Capital | -2,555 | 11,591 | -472 | -1,661 | -28 |
| Other Operating Activity | 30,018 | 7,030 | 658 | 1,344 | 908 |
| Operating Cash Flow | $-88,210 | $-57,837 | $-5,014 | $-10,912 | $-18,762 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -209 | -189 | N/A | -2 | -43 |
| Purchase Of Investment | -520,959 | -329,938 | N/A | N/A | N/A |
| Sale Of Investment | 424,423 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-96,745 | $-330,127 | $N/A | $-2 | $-43 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 24,980 | N/A | N/A | N/A |
| Common Stock Issued | 671 | 54 | N/A | N/A | 24,070 |
| Other Financing Activity | 169,644 | 424,505 | 0 | 0 | -977 |
| Financing Cash Flow | $170,315 | $449,539 | $N/A | $N/A | $23,093 |
| Beginning Cash Position | 61,575 | N/A | 42,445 | 53,359 | 49,071 |
| End Cash Position | 46,935 | 61,575 | 37,431 | 42,445 | 53,359 |
| Net Cash Flow | $-14,640 | $61,575 | $-5,014 | $-10,914 | $4,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,210 | -57,837 | -5,014 | -10,912 | -18,762 |
| Capital Expenditure | -209 | -189 | N/A | -2 | -43 |
| Free Cash Flow | -88,419 | -58,026 | -5,014 | -10,914 | -18,805 |